Prime-O-glucosylcimifugin attenuates lipopolysaccharide-induced acute lung injury in mice.

Chen, Na; Wu, Qianchao; Chi, Gefu; Soromou, Lanan Wassy; Hou, Jinli; Deng, Yanhong; Feng, Haihua

Chen, Na; Wu, Qianchao; Chi, Gefu; Soromou, Lanan Wassy; Hou, Jinli; Deng, Yanhong; Feng, Haihua.

Affiliation

Chen N; College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, PR China.

Int Immunopharmacol ; 16(2): 139-47, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23623941

Subject(s)

Acute Lung Injury/drug therapy; Anti-Inflammatory Agents/therapeutic use; Monosaccharides/therapeutic use; Xanthenes/therapeutic use; Acute Lung Injury/etiology; Acute Lung Injury/immunology; Acute Lung Injury/pathology; Animals; Anti-Inflammatory Agents/pharmacology; Bronchoalveolar Lavage Fluid/immunology; Cell Line; Cytokines/immunology; Lipopolysaccharides; Lung/immunology; Lung/pathology; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases/immunology; Monosaccharides/pharmacology; NF-kappa B/immunology; Xanthenes/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Xanthenes / Acute Lung Injury / Anti-Inflammatory Agents / Monosaccharides Type of study: Etiology_studies Limits: Animals Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2013 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google